The result suggests that oncogenic driver mutations are already present at the premalignant stage, including in LG-DCIS (e.g. SF3B1 c.2098 A > G) or ADH (GATA3 c.925-3_925-2del). Here, GATA3 is linked to ductal breast carcinoma in situ.